INSM实时信号 | 通过Getagraph.com最大化利润

购买 87876 min ago

@ $28.97

发出时间: 28 Feb 2024 @ 22:30

回报率: -12.81%

上一信号: Feb 28 - 04:07

上一信号: 出售

回报率: -1.16 %

Live Chart Being Loaded With Signals

Commentary (29 Apr 2024 @ 23:05):

Stats
今日成交量	115 713
平均成交量	1.74M
市值	3.75B
EPS	$0 ( 2024-02-22 )
下一个收益日期	( $-1.210 ) 2024-05-02
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-4.73
ATR14	$0.0240 (0.10%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-28	Lewis William	Buy	50 000	Common Stock
2024-02-28	Lewis William	Buy	50 000	Stock Option (right to buy)
2024-02-28	Sharoky Melvin Md	Sell	3 600	Common Stock
2024-02-28	Sharoky Melvin Md	Buy	1 200	Common Stock
2024-02-28	Sharoky Melvin Md	Buy	1 200	Common Stock

INSIDER POWER
36.61
Last 100 transactions
Buy: 1 120 971 \| Sell: 555 042

音量相关性

長: -0.42 (neutral)

短: -0.17 (neutral)

Signal:(30.826) Neutral

Insmed Inc 相关性

10 最正相关
ONBPP	0.872
CNDT	0.868
ANNX	0.868
PRAX	0.866
NETE	0.854
ICCC	0.853
WAFDP	0.851
DCOMP	0.847
SRAX	0.846
TTEC	0.846

10 最负相关
RMRM	-0.836
PAIC	-0.832
SVAC	-0.829
EPZM	-0.82
SPRT	-0.816
UNCY	-0.816
TYHT	-0.811
CNST	-0.806
CNCE	-0.804
DRNA	-0.801

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Insmed Inc 相关性 - 货币/商品

0.47
( neutral )

-0.33
( neutral )

0.00
( neutral )

-0.43
( neutral )

0.51
( weak )

-0.13
( neutral )

Insmed Inc 财务报表

Annual	2023
营收:	$305.21M
毛利润:	$239.64M (78.52 %)
EPS:	$-5.34

FY	2023
营收:	$305.21M
毛利润:	$239.64M (78.52 %)
EPS:	$-5.34

FY	2022
营收:	$245.36M
毛利润:	$190.23M (77.53 %)
EPS:	$-3.91

FY	2021
营收:	$188.46M
毛利润:	$144.31M (76.57 %)
EPS:	$-3.88

Financial Reports:

No articles found.

Insmed Inc

Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary arterial hypertension and other rare pulmonary disorders. Insmed Incorporated was founded in 1988 and is headquartered in Bridgewater, New Jersey.

实时更新： Insmed Inc [INSM]

Upcoming Earnings Alert